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Abstract Common genetic variants rs10741657 and
rs10766197 in CYP2R1 and rs4588 and rs842999 in GC
and a combined genetic risk score (GRS) of these four
variants influence late summer 25-hydroxyvitamin D
(25(OH)D) concentrations. The objectives were to identify
those who are most at risk of developing low vitamin D
status during winter and to assess whether vitamin D3-
fortified bread and milk will increase 25(OH)D concen-
trations in those with genetically determined low 25(OH)D
concentrations at late summer. We used data from the
VitmaD study. Participants were allocated to either vitamin
D3-fortified bread and milk or non-fortified bread and milk
during winter. In the fortification group, CYP2R1
(rs10741657) and GC (rs4588 and rs842999) were statis-
tically significantly associated with winter 25(OH)D con-
centrations and CYP2R1 (rs10766197) was borderline
significant. There was a negative linear trend between
25(OH)D concentrations and carriage of 0–8 risk alleles
(p\ 0.0001). No association was found for the control
group (p = 0.1428). There was a significant positive linear
relationship between different quintiles of total vitamin D
intake and the increase in 25(OH)D concentrations among
carriers of 0–2 (p = 0.0012), 3 (p = 0.0001), 4
(p = 0.0118) or 5 (p = 0.0029) risk alleles, but not among
carriers of 6–8 risk alleles (p = 0.1051). Carriers of a high
GRS were more prone to be vitamin D deficient compared
to carriers of a low GRS. Furthermore, rs4588-AA carriers
have a low but very stable 25(OH)D concentration, and
interestingly, also low PTH level.
Keywords SNPs ! Vitamin D ! 25-Hydroxyvitamin D !
D3-fortification ! Genetic risk score ! Vitamin D
insufficiency
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Introduction
In northern latitudes ([40"N), low vitamin D status in
humans, measured as 25-hydroxyvitamin D (25(OH)D)
concentrations, is common during winter months. This is
because vitamin D cannot be synthesized in the skin due to
the lack of solar ultraviolet B radiation (UVB) and because
the average dietary intake of vitamin D is insufficient
(Thuesen et al. 2012). Moreover, twin- and family-based
studies indicate that genetic factors may influence
25(OH)D concentrations appreciably (Engelman et al.
2008; Shea et al. 2009; Karohl et al. 2010). Two genome-
wide association studies (GWAS) and several candidate
gene studies have shown single-nucleotide polymorphisms
(SNPs) to influence 25(OH)D concentrations (Engelman
et al. 2008; Sinotte et al. 2009; Bogh et al. 2010; Ahn et al.
2010; Bu et al. 2010; Zhang et al. 2012; Monticielo et al.
2012; Engelman et al. 2013; Zhang et al. 2013; Nissen
et al. 2014). These SNPs are located in the group-specific
component also known as Gc globulin (GC) and in or near
genes involved in vitamin D synthesis, activation or deg-
radation. These findings indicate that 25(OH)D concen-
trations do not only depend on vitamin D intake and sun
exposure, but also on genetic factors. Thus, genetic factors
may help to identify individuals at risk of low vitamin D
status.
We have previously found genetic variants in CYP2R1
(rs10741657 and rs10766197) and GC (rs4588 and
rs842999) genes to predict late summer 25(OH)D con-
centrations in Danish families in a study of 25 SNPs in
vitamin D metabolism (Nissen et al. 2014). The main focus
of this study is therefore on the influence of rs10741657
and rs10766197 in CYP2R1, and rs842999 and rs4588 in
GC on 25(OH)D concentrations in participants allocated to
either vitamin D3-fortified bread and milk or non-fortified
bread and milk during winter.
CYP2R1, a member of the cytochrome P450 family of
enzymes, is the primary enzyme that hydroxylates vitamin
D to 25(OH)D in the liver. Genetic variants of the CYP2R1
gene are strongly associated with 25(OH)D concentration
(Wjst et al. 2006; Ramos-lopez and Bru¨ck 2007; Bu et al.
2010; Zhang et al. 2012, 2013; Nissen et al. 2014) and
reached a high score in two GWAS (Ahn et al. 2010; Wang
et al. 2010). Furthermore, Ahn et al. (Ahn et al. 2010)
observed heterogeneity between different cohorts in the
GWAS and the association of 25(OH)D concentration with
CYP2R1. A missense mutation in CYP2R1 in exon 2
(L99P) is known to lead to vitamin D deficiency (Cheng
et al. 2004).
Genetic variants in the GC gene reached the highest
score in two GWAS (Ahn et al. 2010; Wang et al. 2010),
and several candidate gene studies have found association
with 25(OH)D concentrations (Lauridsen et al. 2005; Ku-
rylowicz et al. 2006; Abbas et al. 2008; Engelman et al.
2008; Sinotte et al. 2009; Fu et al. 2009; Gozdzik et al.
2011; Lu et al. 2012; Nissen et al. 2014).
The GC gene encodes the vitamin D-binding protein
(DBP), which is the primary vitamin D carrier protein.
DBP binds with high affinity 85–90 % of circulating
25(OH)D, albumin binds with low affinity 10–15 % of
circulating 25(OH)D and less than 1 % of 25(OH)D is in
the free form (Bikle et al. 1986). The main function of DBP
is to stabilize and prolong the half-life of 25(OH)D and
other vitamin D metabolites (Speeckaert et al. 2006). DBP
has several other important biological functions including
fatty acid transportation, extracellular actin scavenging,
leucocyte C5a-mediated chemotaxis, macrophage activa-
tion and stimulation of osteoclasts (Pekkinen et al. 2014).
The most studied GC SNPs are rs4588 and rs7041 that
give rise to three common DBP isoforms, GC1F (rs7041-T,
rs4588-C), GC1S (rs7041-G, rs4588-C) and GC2 (rs7041-
T, rs4588-A), which differ by amino acid composition and
glycosylation (Gozdzik et al. 2011). Vitamin D status dif-
fered significantly depending on rs4588 (or rs2282679,
r2[ 0.99) and/or rs7041 genotypes, where the A-allele of
rs4588 and/or the T-allele of rs7041 were consistently
associated with lower 25(OH)D concentrations (Lauridsen
et al. 2005; Kurylowicz et al. 2006; Abbas et al. 2008;
Engelman et al. 2008; Sinotte et al. 2009; Fu et al. 2009;
Gozdzik et al. 2011; Lu et al. 2012). In Caucasian, rs4588
and rs7041 are in almost complete linkage disequilibrium
(LD) (Haploview software version 4.2). There is biological
support that the affinity to both 25(OH)D and 1,25(OH)2D
is higher for the rs4588 C-allele isoform than for the
A-allele isoform (Arnaud and Constans 1993). Based on
glycosylation patterns, it is suggested that the GC2 phe-
notype is fast metabolizer. Kawakami et al. (1981)
observed that the metabolic rate indeed was higher in GC2-
2 individuals than in GC1-1 individuals. In addition, the
GC2 genotype, which is associated with lower 25(OH)D
concentrations, is also associated with low mean DBP
concentration (Lauridsen et al. 2005). The GC2 and GC1S
isoforms are more frequent in people with light skin
whereas the GC1F isoform is more frequent in people with
dark skin (Kamboh and Ferrell 1986).
Measurement of 25(OH)D concentration in blood is
currently the best biological marker of vitamin D status and
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reflects total vitamin D exposure—from diet, supplements
and cutaneous synthesis. Severe vitamin D deficiency
(\12 nmol/L) is a medical condition associated with
osteomalacia in adults and rickets in children. Vitamin D
deficiency can lead to osteoporosis due to increased bone
resorption caused by increased serum concentrations of
parathyroid hormone (PTH) (Holick 2007). Moreover,
vitamin D deficiency is associated with muscle weakness,
falls and osteoporotic fractures (Lips and van Schoor
2011). Maintaining a sufficient vitamin D status
([50 nmol/L) is important, not only for bone health, but
also because vitamin D deficiency may be associated with
various non-skeletal health outcomes (Borradale and
Kimlin 2009). Thus, a sufficient vitamin D status may have
a disease risk-reduction potential (Grant 2011). Moreover,
a U-shaped association exists between 25(OH)D concen-
trations and risk of cardiovascular disease, certain cancers
and overall mortality (Ross et al. 2011).
There is an on-going international discussion regarding
which cut-off values should define sufficient 25(OH)D
concentrations. There is a general agreement that a
25(OH)D concentration of at least 50 nmol/L is sufficient
(Ross et al. 2011; Nordic Council of Ministers 2014).
Concurrently, some experts argue that a 25(OH)D con-
centration [75 nmol/L is required to achieve sufficient
vitamin D status and non-skeletal benefits (Holick and
Chen 2008; Zhang and Naughton 2010).
It is not easy to determine which doses of vitamin D are
required to achieve sufficient 25(OH)D concentrations. The
Institute of Medicine (IOM) recently reported that a rec-
ommended dietary allowance (RDA) of 15 lg/day for
individuals aged 1–70 years will cover the requirement for
97.5 % of the population in the USA and Canada, corre-
sponding to 25(OH)D concentrations of at least 50 nmol/L
(Ross et al. 2011). Recently, the recommended intakes (RI)
for vitamin D in the Nordic countries were increased from
7.5 to 10 lg/day for individuals aged 2–60 years. This will
cover the requirement for 95 % of the Nordic population
(Nordic Council of Ministers 2004; Nordic Council of
Ministers 2014). Both IOM and Nordic nutrition recom-
mendations (NNRs) 2012 based their RDA and RI on the
relationship between 25(OH)D concentrations and bone
health.
It is a public health concern that vitamin D intakes in
most populations are lower than the RDA or RI (Andersen
et al. 2005; Madsen et al. 2013; Nordic Council of Min-
isters 2014). Food fortification is an effective way to
increase vitamin D intake in the general population
(O’Mahony et al. 2011), thus ensuring that the general
vitamin D intake aligns with the recommendations. During
wintertime, a dietary intake of 10 lg/day is needed to
maintain 25(OH)D concentrations around 50 nmol/L for
the majority of the population in the Nordic countries. For
people with little or no sun-exposure, an intake of 20 lg/
day of vitamin D is recommended (Nordic Council of
Ministers 2014). In Denmark, the mean dietary vitamin D
intake is between 2.0 and 2.9 lg/day and does not meet the
recommendations for the majority of the population (Te-
tens et al. 2011). Thus, during wintertime in Denmark,
50–90 % of the population will develop deficient vitamin
D status between 30 and 50 nmol/L (Andersen et al. 2005;
Thuesen et al. 2012; Madsen et al. 2013).
The main objective of this study was to assess the effect
of real-life use of vitamin D3-fortified bread and milk on
25(OH)D concentrations in relation to common genetic
variants in CYP2R1 (rs10741657 and rs10766197) and GC
(rs4588 and rs842999) in ethnic Danish families with
dependent children during a 6-month winter period and
furthermore to assess whether vitamin D supplementation
will increase 25(OH)D concentration in those with genet-
ically determined low 25(OH)D concentrations. A sec-
ondary objective was to evaluate the amount of vitamin D
needed to maintain a sufficient 25(OH)D concentrations
[50 nmol/L.
Participants and methods
Study design
The present study used data from the VitmaD intervention
conducted in Gladsaxe Municipality in Denmark (latitude
56"N). The study design and methods are described in
detail elsewhere (Madsen et al. 2013). Briefly, a double-
blinded, randomized placebo-controlled intervention trial
with apparently healthy ethnically Danish children and
adults recruited as families was randomly allocated to
either vitamin D3-fortified bread and milk or non-fortified
placebo bread and milk during a 6-month winter period
(September 2010 to April 2011) without sunlight exposure.
The aim of the study design was to investigate a realistic
D3-fortification strategy in real-life settings. Participants
were instructed to replace their usual consumption of bread
and milk with the products provided and in all other
aspects, to live a normal life without changing any habits.
The study was conducted according to the guideline in the
Declaration of Helsinki, and the protocol was approved by
the Danish ethics committee (H-4-2010-020) and registered
in ClinicalTrials.gov (NCT01184716).
Study population
A total of 201 Danish families with dependent children
(n = 782), 4–60 years of age, randomly drawn from the
Danish Civil Registration System, participated in the study.
Inclusion criteria were age between 4 and 60 years and a
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permanent address in the Gladsaxe Municipality in Den-
mark. Exclusion criteria were pregnancy, disease or med-
ication influencing vitamin D metabolism, including
dietary supplements with[10 or[5 lg vitamin D/day for
children or adults, respectively. All the adult participants
and guardians of the children gave written informed
consent.
Vitamin D intakes
The participants’ vitamin D intakes were obtained from a
self-administered web-based questionnaire based on a
semi-quantitative food frequency questionnaire (Andersen
et al. 2005) at baseline and at the end of the study. Dietary
vitamin D intake was calculated based on the self-reported
consumption frequencies and dietary contents of vitamin D
(National Food Institute, Technical University of Den-
mark). Vitamin D intake from dietary supplements was
calculated as self-reported frequency of use multiplied with
the self-reported vitamin D content of the supplements. The
contribution of vitamin D from intakes of vitamin D3-for-
tified bread and milk was calculated based on the self-
reported consumption frequencies, amount and the mea-
sured vitamin D contents in the fortified products
(5.2 ± 0.3 lg/100 g in wheat bread, 4.3 ± 0.3 lg/100 g in
rye bread and 0.38 lg/100 mL in milk) (Madsen et al.
2013). The fortification strategy was to increase vitamin D
intake to 7.5 lg/day as recommended in the Nordic nutri-
tion recommendations (NNRs) until September 2013
(Nordic Council of Ministers 2004). Total vitamin D intake
was estimated as the sum of dietary vitamin D, usage of
multivitamin and vitamin D supplementation and further-
more intake of vitamin D3-fortified bread and milk for the
fortification group.
Biochemical analyses
Non-fasting venous blood samples were drawn, and serum
and plasma were stored at -80 "C until analysis at Clinical
Biochemical Department, Holbæk Hospital, Denmark.
Measurements of serum 25(OH)D concentrations relied on
the determination of both 25(OH)D2 and 25(OH)D3 and
were conducted by isotope dilution liquid chromatography
tandem mass spectrometry (LC–MS/MS). As primary cal-
ibrator, the standard reference material, vitamin D, in
humans (SRM 972) from the National Institute of Stan-
dards and Technology was used. The analytic quality of
25(OH)D assay was assured by Vitamin D External Quality
Assessment Scheme certification, and the mean bias was
-3.2 %. The inter-assay CVs for 25(OH)D2 were 7.6 and
4.6 % at 43 and 150 nmol/L, respectively, and for
25(OH)D3 2.2 and 2.8 % at 30 and 180 nmol/L, respec-
tively, (Madsen et al. 2013). In Denmark, 25(OH)D
concentrations\25 nmol/L are defined as vitamin D defi-
cient, between 25 and 50 nmol/L as vitamin D insufficient
and[50 nmol/L as vitamin D sufficient for the majority of
the population (National Board of Health 2010). 25(OH)D
concentrations can be divided by 2.496 to convert from
nmol/L to ng/ml.
Plasma PTH levels (CV: 3.4 %) was measured by using
immunology analyser Cobas e601 (Roche Diagnostics),
and total calcium (CV 3.4 %) was measured by using a
chemistry analyser Cobas c501 (Roche Diagnostics).
SNP selection and genotyping
In a previous study (Nissen et al. 2014), we genotyped 25
SNPs in seven vitamin D-related genes (CYP2R1,
CYP24A1, CYP27B1, C10orf88, DHCR7/NADSYN1, GC
and VDR) selected based on the reports from two GWAS
and several candidate gene studies. We found a strong
association between common SNPs in CYP2R1 and GC
genes and baseline 25(OH)D concentrations in the pres-
ently studied 201 healthy Danish families with dependent
children. We found that four SNPs, rs10741657 and
rs10766197 in CYP2R1 and rs4588 and rs842999 in GC,
predicted baseline 25(OH)D concentrations. None of the
four SNPs were in LD with each other: rs10741657 and
rs10766196 (Pearson’s r = 0.60), rs10741567 and
rs842999 (Pearson’s r = 0.03), rs10741657 and rs4588
(Pearson’s r = 0.10), rs10766197 and rs842999 (Pearson’s
r = 0.09), rs10766197 and rs4588 (Pearson’s r = 0.05)
and rs842999 and rs4588 (Pearson’s r = 0.0.31) were in
LD. For the tri-allelic rs842999, there was a dose-depen-
dent relationship between 25(OH)D concentrations and
carriers of none, one or two copies of the G-allele and
genotypes are presented as GG, GX and XX, where X
represents C- or A-alleles.
DNA was purified from buffy coats as described by
Miller et al. (1988). SNPs were genotyped using a Se-
quenom# platform (San Diego, California) and the iPLEX
Gold reaction. The SNPs and the primers used are listed in
Supplementary Table 1. Each PCR reaction contained
10 ng genomic DNA, 0.5 U HotStart Taq (Qiagen),
1.25 9 Enzyme Buffer (Qiagen), 3.5 mMMgCl2, 1 mM of
each deoxynucleotide. The primers were added to a final
concentration of 500 nM each. The PCRs were performed
at the following cycling parameters: 15 min preheat to
94 "C, 45 cycles (20 s 94 "C, 30 s 56 "C, 1 min 72 "C)
followed by 3 min 72 "C and stored at -20 "C. The PCR
products were treated with shrimp alkaline phosphatase,
dephosphorylate unincorporated dNTPs and extension with
molecular weight-modified nucleotides were performed in
concordance to the manufacturer’s recommendations. The
PCRs were cleaned with resin and dispend on Spectro-
CHIP# bioarrays. The SpectroCHIP# bioarrays were
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placed in a MALDI-TOF mass spectrometer, and the
results were analysed by MassARRAY Type 4.0 (Seque-
nom) (Nissen et al. 2014).
Of the 782 recruited children and adults, DNA was
obtained from 769 participants (98.3 %). A total of 762
(99.1 %) were successfully genotyped. For quality control,
344 duplicated samples (44 %) were randomly placed
throughout each of the 384-well plates and the reproduc-
ibility was 100 %. No deviation from Hardy–Weinberg
equilibrium was observed for the adult population (v2
testing, p[ 0.05).
Statistical analysis
All statistical analyses were carried out using SAS Enter-
prise Guide 4.3 (SAS Institute, Inc., Cary. USA). Linear
mixed models with family as a random factor were applied
in all analyses to account for the non-independency of the
participants. Before analysis, 25(OH)D concentrations and
PTH levels were log-transformed to approximate a normal
distribution and all means are presented as geometric
means, unless otherwise specified. A nominal p value of
0.05 was considered statistically significant.
The following categorical variables were used: age
(4–11, 12–17, 18–40, 41–60 years), sex (male, female),
BMI (underweight, normal weight, overweight, obese)
according to standards for children (Cole et al. 2000) and
the WHO International standards for adults (World Health
Organization 2000) measured at baseline, went on ski and
sun vacation during the study period (yes, no), solarium use
at least once a week (yes, no) and total calcium at baseline
and at the end of the study. The continuous variables are
log 25(OH)D concentrations and log PTH levels at baseline
and at the end of the study, total vitamin D intake from
diet, multivitamins and vitamin D supplements (lg/day).
A genetic risk score (GRS) was calculated as the sum of
number of risk alleles. The GRS (range 0–8) was calculated
as the sum of number of G-alleles of rs10741657, A-alleles
of rs10766197, A-alleles of rs4588 and C/A-alleles of
rs842999. A linear mixed model, adjusted for family and
confounding variables, was fitted to the log 25(OH)D
concentration with GRS as an explanatory factor. The
Table 1 Basic characteristics
of the study population
(n = 762)
All means are presented as
geometric means with 95 %
confidence interval in
parentheses. Continuously
variables are tested with t test,
and categorical variable are
tested with Chi-square
Bold numbers represent
significant P values
Fortification group Control group p value
Participants (n) 377 385 –
Female/male (n) 191/186 199/186 0.7771
Age (n) 0.5430
4–10 years 94 91 0.5893
11–17 years 75 88 0.7064
18–40 years 111 87 0.4928
41–60 years 97 119 0.4802
BMI (kg/m2) 21.7 (21.17–22.3) 21.9 (21.3–22.4) 0.5515
25(OH)D (nmol/L)
Baseline 72.7 (70.8–74.7) 71.1 (68.9–73.3) 0.4688
End 67.1 (65.2–69.0) 41.5 (39.6–43.5) <0.0001
PTH (ng/L)
Baseline 35.3 (34.1–36.5) 34.5 (33.3–35.7) 0.2473
End 36.8 (35.5–38.1) 40.1 (38.7–41.6) 0.0199
Total calcium (mmol/L)
Baseline 2.44 (2.43–2.45) 2.45 (2.44–2.46) 0.0438
End 2.43 (2.42–2.44) 2.43 (2.42–2.44) 0.8165
Total vitamin D intake (lg/day)
Baseline 2.9 (2.8–3.1) 2.7 (2.5–2.9) 0.4972
End 11.7 (11.0–12.4) 4.1 (3.8–4.5) <0.0001
Supplement users (n)
Baseline 127 127 0.7163
End 230 242 0.5991
Ski and sun vacation during the study (n) 135 100 0.0006
Solarium users during the study (n) 0 8 0.0059
Sunscreen use (n)
Always/most times/sometimes/seldom 82/108/144/36 105/114/132/32 0.3361
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adjusted mean concentration of 25(OH)D was calculated
for each GRS. All the analyses were performed for control
and fortification group and separately for adults and
children.
Furthermore, each GRS category was stratified by
quintile of total vitamin D intake (Q1: 0–2.9 lg/day; Q2:
3–7.4 lg/day; Q3: 7.5–9.9 lg/day; Q4: 10.0–14.9 lg/day;
and Q5:[15.0 lg/day). Total vitamin D intake was esti-
mated as the sum of dietary vitamin D, use of multivitamin
and vitamin D supplementation and, for the fortification
group, intake of vitamin D3-fortified bread and milk. The
final concentration of 25(OH)D was estimated for each
GRS by intake groups adjusted for family and confounding
variables.
The prevalence (%) of participants with sufficient
([50 nmol/L) 25(OH)D concentrations was estimated for
each GRS by intake groups adjusted for family and con-
founding variables.
Results
Of the 782 recruited children and adults, 762 participants
had complete questionnaire data, genotypes and 25(OH)D
A
B
C
Fig. 1 Association of
rs10741657, rs10766197,
rs4588 and rs842999 with PTH
levels at baseline for all the
participants and stratified by
fortification and group control at
the end of the study. Results are
presented as unadjusted and
adjusted geometric means. At
baseline, the following variables
were adjusted for age, sex, BMI,
vacation and baseline total
calcium, and at end of the study,
the following variables were
adjusted for age, sex, BMI,
vacation, baseline 25(OH)D
concentration, baseline PTH
levels and end total calcium.
Adjusted p values are given for
each genotype. The numbers in
the columns present the total
numbers of participants carrying
this genotype. Error bars
indicate 95 % confidence
interval. A statistically
significant difference in PTH
levels was observed for rs4588
in both the fortification and
control group at the end of the
study
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concentrations measured at baseline. At the end of the
study, a total of 756 participants (control group n = 384
and fortification group n = 384) had complete question-
naire data, genotypes and 25(OH)D concentrations mea-
sured. Characteristics of the study population are listed in
Table 1, as previously described in detail elsewhere
(Madsen et al. 2013; Nissen et al. 2014). At baseline,
participants in the control group had significantly higher
total calcium levels (p = 0.0438) compared to participants
in the fortification group, as previously reported (Madsen
et al. 2013). Furthermore, there was a statistically signifi-
cant difference between the control and fortification group
for the use of solarium (p = 0.0059), and ski and sun
vacation (p = 0.0006) during the intervention period as
previously reported (Madsen et al. 2013).
In a previous study (Nissen et al. 2014), we found that at
baseline, CYP2R1 (rs10741657 and rs10766197) and GC
(rs4588 and rs842999) were strongly associated with
25(OH)D concentrations among all participants (Table 2).
At the end of the study, no associations between SNPs
rs10741657 and rs10766197 in CYP2R1 or rs4588 and
rs842999 in GC and 25(OH)D concentrations were found
for the control group. For the fortification group,
rs10741657 in CYP2R1 and rs4588 and rs842999 in GC
were statistically significantly associated with 25(OH)D
concentrations. The association with CYP2R1
(rs10766197) was borderline significant (p = 0.0599). At
the end of the study, total vitamin D intake (p\ 0.0001)
and 25(OH)D concentrations (p\ 0.0001) were, as
expected, significantly higher in the fortified group com-
pared to the control group as previously reported (Madsen
et al. 2013).
There was no difference in PTH levels when stratified
by rs10741657, rs10766197, rs4588 and rs842999 for all
the participants at baseline (Fig. 1). As anticipated, PTH
levels were significantly higher in the control group
compared to the fortification group (p = 0.0199) at the
end of the study (Table 1). Furthermore, there was a
significant difference in PTH levels for rs4588 in both the
fortification group (p = 0.0064) and control group
(p = 0.0132) at the end of the study. Carriers of the
rs4588-AA genotype had significantly lower PTH levels
compared to carriers of either the rs4588-CA or rs4588-
CC genotype.
The prevalence of participants with 25(OH)D concen-
tration \30 nmol/L and \50 nmol/L was estimated for
each genotype of rs10741657, rs10766197, rs4588 and
rs842999 for all the participants at baseline and separately
for the control and fortification group at the end of the
study (Fig. 2a, b).
At baseline, there was no difference in the prevalence of
participants having 25(OH)D concentrations\30 nmol/L
A
B
Fig. 2 The prevalence (%) of
\30 nmol/L a and\50 nmol/L
b 25(OH)D concentrations in
carriers of different genotypes
of rs10741657, rs10766197,
rs4588 and rs842999 at baseline
for all the participants and at the
end of the study stratified by
control and fortification group.
Cut-off value of 25(OH)D
\50 nmol/L defines the
requirement for optimal bone
health for the majority of the
population, and cut-off value
\30 nmol/L defines the
25(OH)D concentration at
which adverse effects on bone
health may be expected (Ross
et al. 2011)
413 Page 8 of 15 Genes Nutr (2014) 9:413
123
stratifying by genotype rs10741657, rs10766197, rs4588
and rs842999 (p = 0.2269, 0.1715, 0.6953 and 0.5111),
respectively. In contrast, there was significant difference in
the prevalence of participants having 25(OH)D concen-
trations\50 nmol/L for rs10741657, rs4588 and rs842999
(p = 0.0004, \0.0001 and 0.0435), respectively, and
rs10766197 was borderline significantly associated
(p = 0.0743).
At the end of the study, for the fortification group, a
significant difference in the prevalence of participants
having 25(OH)D concentrations was found for rs4588
(p = 0.0023\ 30 nmol and for\50 nmol/L p = 0.0002)
and rs842999 (p = 0.0029\ 50 nmol/L). No difference in
prevalence was observed for rs10741657 and rs10766197
(p = 0.5830 and 0.2348 for \30 nmol/L and for
\50 nmol/L p = 0.5466 and 0.6652), respectively. Fur-
thermore, no difference in prevalence was found for
rs842999 (p = 0.1194 for\30 nmol/L).
For the control group, only rs842999\30 nmol/L was
significant (p = 0.0455). No significant difference was
observed for rs10741657, rs10766197 and rs4588
(p = 0.8694, 0.6130 and 0.2651\ 30 nmol/L and
A 
B
C
Fig. 3 Estimated mean
25(OH)D concentrations at the
end of the study for each genetic
risk score category stratified by
control and fortification group,
separately for all (a), adults
(b) and children (c). Individuals
carrying 7 or 8 (7–8) risk alleles
were combined due to small
sample size. Genetic risk score
(range 0 to 7–8) was calculated
as the sum of number of
G-alleles of rs10741657,
A-alleles of rs10766197,
A-alleles of rs4588 and C/A-
alleles of rs842999. The
numbers in the columns present
the total numbers of participants
carrying the risk score. Error
bars indicate 95 % confidence
interval
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p = 0.5645, 0.4948 and 0.2641 for\50 nmol/L), respec-
tively. Furthermore, rs842999\50 nmol/L was also found
to be non-significant (p = 0.3402). In general, the lowest
prevalence of vitamin D deficiency\30 and\50 nmol/L
was observed at baseline (p = 0.0001 and 0.0001),
respectively. Participants in the control group presented
more often with vitamin D deficiency\30 and\50 nmol/L
compared to the fortification group (p = 0.0001 for
\30 nmol/L and for\50 nmol/L p = 0.0001),
At the end of the study, to determine the combined
contributions of rs10741657, rs10766197, rs4588 and
rs842999, a GRS was calculated individually for the
control and fortification group and separately for all,
adults and children (Fig. 3a–c). Participants carrying
seven or eight (7–8) risk alleles were combined due to
small sample size. The coefficients for rs10741657,
rs10766197, rs4588 and rs842999 were very similar in a
mixed regression model including all SNPs, and there-
fore, it was not necessary to weight the different risk
alleles by the correlation coefficient. A linear mixed
model with family as a random factor, adjusted for age,
sex, BMI, total vitamin D intake, and ski and sun
vacation showed that for the control group, there was no
difference in 25(OH)D concentrations for carriers of 0 to
7–8 risk alleles (p = 0.1428, 0.2881 and 0.7667) for all,
adults and children, respectively. For the fortification
group, there was a negative linear trend between
25(OH)D concentrations and carriers of 0 to 7–8 risk
alleles for all, adults and children (p\ 0.0001, 0.0025
and 0.0023, respectively). Overall, there was a mean
difference in 25(OH)D concentrations of 28.2, 28.6 and
31.9 nmol/L between carriers of no risk alleles and
Fig. 4 Mean 25(OH)D concentrations at the end of the study for each
genetic risk score category stratified by total vitamin D intakes for the
study population. Total vitamin D intake was estimated as the sum of
dietary vitamin D, usage of multivitamin and vitamin D supplemen-
tation and, for the fortification group, intake of vitamin D3-fortified
bread and milk. The following quintile stratification was used:
quintile 1: 0–2.9 lg/day; quintile 2: 3–7.4 lg/day; quintile 3:
7.5–9.9 lg/day; quintile 4: 10.0–14.9 lg/day; and quintile 5:
[15.0 lg/day. Genetic risk score (range 0–8) was calculated as the
sum of number of G-alleles of rs10741657, A-alleles of rs10766197,
A-alleles of rs4588 and C/A-alleles of rs842999. Individuals carrying
0, 1 or 2 (0–2) risk alleles and individuals carrying 6, 7 or 8 (6–8) risk
alleles were combined due to small sample size after quintile
stratification by total vitamin D intake. The numbers in the columns
present the total numbers of participants carrying this risk score.
Error bars indicate 95 % confidence interval
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carriers of all 7–8 risk alleles in all, adults and children,
respectively. Overall, the same GRS pattern was
observed for adults and children.
We estimated the effect of total vitamin D intake for
each category GRS (range 0–8), for the combined contri-
butions of rs10741657, rs10766197, rs4588 and rs842999
(Fig. 4). Each participant was stratified by quintile of total
vitamin D intake. Total vitamin D intake was estimated as
the sum of dietary vitamin D, use of multivitamin and
vitamin D supplements and, for the fortification group,
self-reported intake of vitamin D3-fortified bread and milk.
Quintile stratification for total vitamin D intake was based
on different RDA or RI:\3 lg/day (no supplementation),
\7.5 lg/day (old NNRs 2004),\10 lg/day (present NNRs
2012),\15 lg/day (IOM) or[15 lg/day. The following
quintile stratification cut-off values were used: quintile 1:
0–2.9 lg/day; quintile 2: 3–7.4 lg/day; quintile 3:
7.5–9.9 lg/day; quintile 4: 10.0–14.9 lg/day and quintile
5:[15.0 lg/day. The control and fortification groups were
combined in the linear mixed model. Individuals carrying
0, 1 or 2 (0–2) risk alleles or individuals carrying 6, 7 or 8
(6–8) risk alleles were combined due to small sample sizes
after quintile stratification by total vitamin D intake. A total
of 25.1, 22.4, 23.4, 15.6 and 13.6 % of the adult partici-
pants carried 0–2, 3, 4, 5 or 6–8 risk alleles, respectively.
The majority of the participants in the control group had
low total vitamin D intake and were therefore primarily
located in the first two quintiles. In general, there was a
statistically significant, positive linear relationship between
total vitamin D intake and 25(OH)D concentrations among
carriers of 0–2, 3, 4 or 5 risk alleles, (p = 0.0012, 0.0001,
0.0118 and 0.0029, respectively). For individuals carrying
6–8 risk alleles, there was no statistically significant rela-
tionship between total vitamin D intake and 25(OH)D
concentrations (p = 0.1051).
A the end of the winter season in Denmark, a total
vitamin D intake of\3 lg/day was not sufficient for 95 %
of the study population to achieve sufficient ([50 nmol/L)
25(OH)D concentrations, regardless of the number of risk
alleles they carried (Fig. 4). For participants carrying 0–2
or 3 risk alleles, a total daily vitamin D intake between 3
and 7.4 lg seemed to be sufficient for 95 % of the study
population to achieve sufficient 25(OH)D concentrations.
For participants carrying four risk alleles, a total daily
vitamin D intake[7.5 lg seemed to be sufficient for 95 %
of the study population to achieve sufficient 25(OH)D
concentrations. For participants carrying five risk alleles, a
total daily vitamin D intake[10 lg seemed to be sufficient
for 95 % of the study population to achieve sufficient
25(OH)D concentrations. For participants carrying 6–8 risk
alleles, a total daily vitamin D intake[15 lg was almost
enough for 95 % of the study population to achieve suffi-
cient 25(OH)D concentrations.
In addition, we determined the percentage of partici-
pants with sufficient 25(OH)D concentrations (Fig. 5).
Sufficient 25(OH)D concentrations were achieved for all
Fig. 5 The prevalence (%) of sufficient 25(OH)D concentrations,
defined as[50 nmol/L, for each genetic risk score category stratified
by quintile of total vitamin D intake at the end of the study. Total
vitamin D intake was estimated as the sum of dietary vitamin D, use
of multivitamin and vitamin D supplements and, for the fortification
group, intake of vitamin D3-fortified bread and milk. The following
quintile stratification was used: quintile 1: 0–2.9 lg/day; quintile 2:
3–7.4 lg/day; quintile 3: 7.5–9.9 lg/day; quintile 4: 10.0–14.9 lg/
day; and quintile 5:[15.0 lg/day. Genetic risk score (range 0–8) was
calculated as the sum of number of G-alleles of rs10741657, A-alleles
of rs10766197, A-alleles of rs4588 and C/A-alleles of rs842999.
Individuals carrying 0, 1 or 2 (0–2) risk alleles and individuals
carrying 6, 7 or 8 (6–8) risk alleles were combined due to small
sample size after quintile stratification by total vitamin D intake
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participants carrying 0–2, 3 or 4 risk alleles and who
consumed[15 lg/day of vitamin D. For participants car-
rying 5 or 6–8 risk alleles, this fell to 86 and 90 %,
respectively. Furthermore, sufficient 25(OH)D concentra-
tions were achieved for 87, 90, 83, 84 and 67 % of the
participants carrying 0–2, 3, 4, 5 or 6–8 risk alleles and
who consumed 10–14.9 lg/day. This fell to 80, 76, 86, 50
and 53 % and 57, 50, 61, 52 and 41 % for participants
carrying 0–2, 3, 4, 5 or 6–8 risk alleles and who consumed
7.5–9.9 lg/day or 3.0–7.4 lg/day of vitamin D,
respectively.
Discussion
In the present study, we show that genetic variation influ-
ences 25(OH)D concentrations considerably. Genetically
predisposed individuals carrying 6–8 risk alleles of
rs10741657 and rs10766197 in CYP2R1 and rs4588 and
rs842999 in GC need[15 lg/day or more vitamin D to
reach 25(OH)D concentrations[50 nmol/L during winter.
Furthermore, there was a statistically significant dose-
dependent relationship between 25(OH)D concentration
and total vitamin D intake for carriers of 0–5 risk alleles of
SNPs rs10741657 and rs10766197 in CYP2R1 and rs4588
and rs842999 in GC. A dose-dependent relationship was
also observed for carriers of 6–8 risk alleles, but the
increase in 25(OH)D concentrations was not statistically
significant.
At baseline, our study showed that there was statistically
significant difference in the prevalence of participants
presenting with 25(OH)D concentration \50 nmol/L for
rs10741657, rs10766197, rs4588 and rs842999. The sig-
nificant differences in prevalence disappeared during the
winter for the control group, but were maintained for
rs4588 and rs842999 in the fortification group. For the
fortification group, the highest prevalence of 25(OH)D
\50 nmol/L was observed for the rs4588-AA genotype. In
contrast, in the control group, rs4588-AA carriers had the
lowest prevalence of 25(OH)D\50 nmol/L. This indicates
that although carriers of the rs4588-AA genotype in the
fortification group were more prone to be vitamin D defi-
cient, rs4588-AA carriers in the control group were less
prone to be vitamin D deficient. This may indicate that
rs4588-AA carriers have a somewhat low but very stable
25(OH)D concentrations. Paradoxically, a recessive effect
was observed for rs4588-AA carriers on PTH levels in both
the fortification and control group at the end of the study.
Participants with the rs4588-AA genotype have the lowest
PTH levels and 25(OH)D concentrations compared to
rs4588-CC or rs4588-CA carriers. Similar to our findings,
Pekkinen et al. (2014) found a dose–response effect of
rs4588 on PTH concentrations in 231 Finnish children and
adolescents aged 7–19 years, with rs4588-AA carriers
having the lowest PTH and 25(OH)D concentrations.
Further studies are warranted to investigate the underlying
biological mechanism of this observation.
At the end of the study, there was a pronounced positive
effect of real-life usage of vitamin D3-fortified bread and
milk on 25(OH)D concentrations. For the fortification
group, 25(OH)D concentrations were significantly associ-
ated with rs10741657 in CYP2R1, and with rs4588 and
rs842999 in GC. Furthermore, rs10766197 in CYP2R1 was
borderline significantly associated with 25(OH)D concen-
trations. These winter results resemble the results found at
baseline (late summer) and indicate that when vitamin D is
received primarily as vitamin D3-food fortification during
the winter, the association between 25(OH)D concentra-
tions and genetic variation observed at late summer for
rs10741657 and rs10766197 in CYP2R1 and rs4588 and
rs842999 in GC is maintained. In contrast, the baseline
association between 25(OH)D concentrations and
rs10741657 and rs10766197 in CYP2R1 and rs4588 and
rs842999 in GC disappeared during the winter for the
control group. Our findings are consistent with the findings
from two previous studies (Gozdzik et al. 2011; Engelman
et al. 2013). Gozdzik et al. (2011) found that rs4588 in GC
was associated with 25(OH)D concentrations in Canadians
of European descent during the fall (p = 0.009), but not
during the winter (p = 0.535). Similarly, Engelman et al.
(Engelman et al. 2013) found two SNPs in GC (rs4588 and
rs7041) and four SNPs in CYP2R1 (rs105000804,
rs11023380, 2060763, 11023374) to be strongly associated
with 25(OH)D concentrations in individuals whose blood
was drawn in summer but not in individuals whose blood
was drawn in winter month.
Engelman et al. (2013) performed a GRS for rs4588 in
GC and rs2060793 in CYP2R1. The risk scores were highly
significantly associated with 25(OH)D concentrations in
individuals with high external source of vitamin D
([10 lg/day) but not in individuals with low external
source of vitamin D (\10 lg/day). In addition, Gozdzik
et al. (2011) found that vitamin D intake was significantly
predictive of 25(OH)D concentrations in individuals car-
rying the rs4588 (T436 K) or in GC diplotypes during fall
and winter. Our results support these findings by Engelman
et al. (2013) and Gozdzik et al. (2011). We performed a
GRS including the four SNPs rs10741657 and rs10766197
in CYP2R1 and rs4588 and rs842999 in GC. For the for-
tification group, the GRS was highly significantly associ-
ated with 25(OH)D concentrations (p\ 0.0001) but not for
the control group (p = 0.1428) during winter. In general,
children had higher mean 25(OH)D concentrations com-
pared to adults. For the fortification group, an explanation
could be that the children consumed more vitamin D3-
fortified bread and milk compared to the adults.
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Approximately 90 % of the total intake of consumed bread
and milk was the products provided by the study, with no
difference in compliance between children and adults
(Madsen et al. 2013). In general, the children were more
often multivitamin users compared to the adults (Madsen
et al. 2013).
When stratifying total vitamin D intake into quintiles,
our data suggest that it is difficult to raise 25(OH)D con-
centrations to a sufficient level in participants carrying 6–8
risk alleles with vitamin D3-fortified bread and milk. A
statistically non-significant increase in 25(OH)D concen-
trations was found comparing the lowest and highest
quintile of vitamin D intake for participants carrying 6–8,
but with a much lower rate (?D17.6 nmol/L) compared to
participants carrying 0–2, 3, 4 or 5 risk alleles (?D28.8,
36.5, 24.2 and 33.6 nmol/L), respectively, (Fig. 4). Whe-
ther this also applies for vitamin D synthesized in the skin
during UVB exposure remains to be further investigated.
These increases are similar to the findings by Engelman
et al. (2013). They found that among individuals carrying
3–4 risk alleles of GC (rs4588) and CYP2R1 (rs2060793),
the lowest increase in 25(OH)D concentrations was
observed in individuals carrying 3–4 risk alleles
(?D16.7 nmol/L) compared to individuals with fewer risk
alleles (?D27.7 nmol/L).
In our study population, 67 % of the participants car-
rying 6–8 risk alleles had sufficient 25(OH)D concentra-
tions in contrast to 87, 90, 83 and 84 % for participants
carrying 0–2, 3, 4 or 5 risk alleles, respectively, when
following IOMs RDA of 15 lg/day for individuals aged
1–70 years. Following the Nordic countries RI of 10 lg/
day for individual aged 2–60 years, only 50 and 53 % of
the participants carrying 5 or 6–8 risk alleles, respectively,
had sufficient 25(OH)D concentrations compared to 80, 76
and 86 % of the participants carrying 0–2, 3 or 4 risk
alleles, respectively. This indicates that genetic predispo-
sition may have a large impact on 25(OH)D concentrations.
Participants having a high GRS may need a higher amount
of vitamin D supplementation than participants carrying a
lower GRS in order to reach sufficient 25(OH)D concen-
trations. We provide evidence that participants with dif-
ferent genetic profiles need different amounts of vitamin D
supplementation to achieve sufficient 25(OH)D concen-
trations. Epidemiological studies have found association
between blood levels of vitamin D concentrations and risk
of cancer, but the significance of genetically determined
low vitamin D concentration is not clear.
In agreement with our findings, Cranney et al. (2007)
concluded that vitamin D3-doses of 10–20 lg/day may be
insufficient to prevent vitamin D deficiency in at-risk
individuals. Cashman et al. (2011) concluded that for a
population to achieve 25(OH)D concentrations of 50 nmol/
L, an average intake of 9 lg/day vitamin D was needed.
Nevertheless, taking inter-individual variation into account
23.5 lg/day of vitamin D3 was needed for 95 % of the
population to reach a 25(OH)D concentration of 50 nmol/
L. Engelman et al. (2013) found that all of the individuals
with no risk alleles of rs4588 and rs2060793 who con-
sumed at least 17 lg/day (670 IU/day) had 25(OH)D
[50 nmol/L. This fell to 84, 72 and 62 %, respectively, for
individuals carrying 1, 2 or 3–4 risk alleles who also
consumed at least 17 lg/day.
Our study has several strengths in that we ensured a
large age span (4–60 years), had both genders represented,
and both children and adults were included due to the
family-based design (Madsen et al. 2013). 25(OH)D con-
centrations were measured by a specific analytical method
(LC–MS/MS). We took into account that non-genetic
factors such as vitamin D intake and season are known to
influence 25(OH)D concentrations. We estimated total
vitamin D intake, and blood samples were drawn during the
same seasons for all the participants. A disadvantage is that
some of the known predictors of 25(OH)D concentration
were quantified by self-reported questionnaire data.
In summary, we found that after consuming vitamin D3-
fortified bread and milk during a winter season, the effect
of genetic variation in the CYP2R1 and GC genes on
25(OH)D concentrations resembles the results found in late
summer. The association with genetic variation observed
for CYP2R1 and GC genes in late summer disappeared
during the winter season for the control group. We found
that carriers of the rs4588-AA genotype had the highest
prevalence of 25(OH)D concentration \50 nmol/L at
baseline and at the end of the study for the fortification
group. In contrast, rs4588-AA carriers in the control group
had the lowest prevalence. It seems like rs4588-AA carriers
have a low but very stable 25(OH)D concentration, and
interestingly, also low PTH level.
In this study, we demonstrated that carriers of a high GRS
of CYP2R1 (rs10741657 and rs10766197) and GC (rs4588
and rs842999) are more prone to be vitamin D deficient
compared to carriers of a low GRS. Furthermore, carriers of a
high GRS may need a higher amount of vitamin D3 supple-
mentation to achieve sufficient 25(OH)D concentrations.
Importantly, for public health recommendations, it seems that
with increasing vitamin D intake, genetically determined low
risk carriers with sufficient 25(OH)D concentrations achieve
even higher 25(OH)D concentrations with the used real-life
vitamin D3-fortification model.
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